The cryoglobulins: An overview

European Journal of Clinical Investigation

Volumn 31, Issue 7, 2001, Pages 628-638

  Dammacco, F ^a   Sansonno, D ^b   Piccoli, C ^a   Tucci, F A ^a   Racanelli, V ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Cryoglobulinemia; Hepatitis C virus (HCV); Lymphoproliferation; Rheumatoid factor (RF)

Indexed keywords

CRYOGLOBULIN; IMMUNOGLOBULIN; RHEUMATOID FACTOR;

ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; CRYOGLOBULINEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

CRYOGLOBULINEMIA; CRYOGLOBULINS; HEPATITIS C; HUMANS; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; SYNDROME; VASCULITIS;

EID: 0034945480     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00824.x     Document Type: Review

References (96)

1. Hyperproteinemia associated with multiple myeloma
2. Studies of cryoglobulins. I. Unusual purpura associated with the presence of high concentration of cryoglobulin (cold precipitable serum globulin)
3. Cryoglobulinemia: A study of 29 patients. I. IgG and IgM cryoglobulins and factors effecting cryoprecipitability
4. Nomenclature of systemic vasculitides: Proposal of an international consensus conference
5. The presence of cryoprecipitable immunoglobulins in normal human sera may reflect specific molecular interactions
6. Evidence for somatic selection of natural autoantibodies
7. A role for hepatitis C virus infection in type II cryoglobulinemia
8. Antibodies to hepatitis C virus in essential mixed cryoglobulinemia
9. Biological and clinical significance of cryoglobulins: A report of 86 cases
10. Characterization of cryoglobulins by immunoblotting
11. Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide
12. Immunochemical characterization of monoclonal IgG containing mixed cryoglobulins
13. IgG3 is the major source of cryoglobulins in mice
14. Crioglobulinemia e piroglobulinemia
15. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins
16. The clinical implications of monoclonal immunoglobulins
17. Immunological abnormalities and hepatotropic viral infections
18. Systemic vasculitis in a district general hospital 1972-80: Clinical and laboratory features, clarification and prognosis in 80 cases
19. Renal manifestations of hepatitis C infection
20. Hepatitis C virus infection and mixed cryoglobulinemia: A striking association
21. Hepatitis C infection, cryoglobulinemia, and vasculitis neuropathy. Treatment with interferon alfa. Case report and review of the literature
22. Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up
23. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis
24. Association between hepatitis B virus and essential mixed cryoglobulinemia
25. Hepatitis C virus in patients with cryoglobulinemia type II
26. Association between hepatitis C virus and mixed cryoglobulinemia
27. Mixed cryoglobulinemia and hepatitis C virus
28. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes
29. Mixed cryoglobulinemia as a model of systemic vasculitis
30. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: An emerging picture
31. Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection
32. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia
33. Mixed cryoglobulinemia cross-reactive idiotypes: Implications for the relationship of MC to rheumatic and lymphoproliferative diseases
34. A solution to the rheumatoid factor paradox. Pathologic rheumatoid factors can be tolerized by competition with natural rheumatoid factors
35. New roles for rheumatoid factor
36. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response
37. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation
38. Rheumatoid factors in immune complexes of patients with rheumatoid arthritis
39. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation
40. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia
41. Mixed cryoglobulinemia: New concepts
42. Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG
43. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen
44. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome
45. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma
46. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia
47. Hepatitis C virus and non-Hodgkin's lymphomas
48. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders
49. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy
50. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection
51. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma
52. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course
53. Primary hepatic lymphoma in a patient with chronic hepatitis C
54. Primary lymphoplasmacytic lymphoma of the liver associated with a serum monoclonal peak of IgG kappa
55. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia
56. The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis C virus infection
57. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma
58. Malignant lymphoproliferative disorders in liver cirrhosis
59. Hepatocellular carcinoma and B-cell tumors
60. Primary hepatic lymphoma in a man with chronic hepatitis C
61. Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection
62. Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia
63. Gammapathie monoclonale apparemment non myélomateuse associée à l'antigène de l'hépatite non-A non-B
64. Monoclonal gammopathy in chronic active hepatitis
65. HCV and monoclonal gammopathies
66. Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia
67. Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection
68. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus
69. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy
70. The lymphoid system in hepatitis C virus: Autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy
71. Hepatitis C virus infection involves CD34+ hematopoietic progenitor cells in hepatitis C virus chronic carriers
72. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver
73. The role of hepatitis C virus in the aetiology of non-Hodgkin's lymhoma. A regional association?
74. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center
75. No association between hepatitis C and B-cell lymphoma
76. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon
77. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia
78. Interferon-alpha in mixed cryoglobulinemia patients: A randomized, crossover-controlled trial
79. Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: A long-term, randomized, controlled study
80. Circulating levels and liver tissue distribution of intercellular adhesion molecule-1 during beta-interferon therapy of hepatitis C virus-associated chronic active liver disease
81. Interferon alpha 2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
82. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C
83. Randomised trial of interferon α2b plus ribavirin for 48 weeks for treatment of chronic infection with hepatitis C virus
84. Interferon and ribavirin therapy in patients with chronic hepatitis C and mixed cryoglobulinemia
85. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha
86. Conquering hepatitis C, step by step
87. Interferon-alpha may exacerbate cryoglobulinemia-related ischemic manifestations: An adverse effect potentially related to its anti-angiogenic activity
88. Therapeutic approaches in mixed cryoglobulinemia
89. Glomerulonephritis in renal allografts associated with hepatitis C infection: A possible relationship with transplant glomerulopathy in two cases
90. Recurrence of membranoproliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C
91. The effect of combination therapy with interferon and cryofiltration on mesangial proliferative glomerulonephritis originating from mixed cryoglobulinemia in chronic hepatitis C virus infection
92. Therapeutic plasma exchange for the treatment of rapidly progressive glomerulonephritis
93. Membranoproliferative glomerulonephritis and demyelinating neuropathy caused by type II mixed cryoglobulinemia associated with HCV infection
94. Mixed cryoglobulinemia in HIV-1 infection: The role of HIV-1
95. Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection
96. Cryofiltration apheresis in the treatment of cryoprecipitate induced diseases